Reply

Affiliations

¹ Ophthalmic Oncology Service; Weill Cornell Medical Center, New York, New York. Electronic address: francij1@mskcc.org.
² Ophthalmic Oncology Service; Weill Cornell Medical Center, New York, New York.
³ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York.
⁴ Ophthalmic Oncology Service.
⁵ Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland.
⁶ Retina Service, Massachusetts Eye and Ear Harvard Medical School, Boston, Massachusetts.

Comment

Jasmine H Francis et al. Ophthalmology. 2020 Nov.

. 2020 Nov;127(11):e106-e107.

doi: 10.1016/j.ophtha.2020.05.044. Epub 2020 Jul 29.

¹ Ophthalmic Oncology Service; Weill Cornell Medical Center, New York, New York. Electronic address: francij1@mskcc.org.
² Ophthalmic Oncology Service; Weill Cornell Medical Center, New York, New York.
³ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York.
⁴ Ophthalmic Oncology Service.
⁵ Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland.
⁶ Retina Service, Massachusetts Eye and Ear Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Immune Checkpoint Inhibitor-Associated Optic Neuritis.
Francis JH, Jaben K, Santomasso BD, Canestraro J, Abramson DH, Chapman PB, Berkenstock M, Aronow ME. Francis JH, et al. Ophthalmology. 2020 Nov;127(11):1585-1589. doi: 10.1016/j.ophtha.2020.05.003. Epub 2020 May 8. Ophthalmology. 2020. PMID: 32437864 Free PMC article.
Re: Francis et al.: Immune checkpoint inhibitor associated optic neuritis (Ophthalmology. 2020;127:1585-1589).
Micieli JA, Margolin E. Micieli JA, et al. Ophthalmology. 2020 Nov;127(11):e105-e106. doi: 10.1016/j.ophtha.2020.05.043. Epub 2020 Jul 29. Ophthalmology. 2020. PMID: 32739191 No abstract available.